EE207 Healthcare Utilization and Costs in New Users of Once-Weekly GLP-1 Receptor Agonists vs Other Glucose-Lowering Therapies Among Medicare Beneficiaries With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease
Abstract
Authors
Adam de Havenon Xi Tan Sina Noshad Joanna Harton Yuanjie Liang Lin Xie Josh Noone